• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Crude Oil Rises 1%; Rover Group Shares Spike Higher

    11/29/23 12:05:22 PM ET
    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Industrial Machinery/Components
    Miscellaneous
    Get the next $BIVI alert in real time by email

    U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 50 points on Wednesday.

    The Dow traded up 0.17% to 35,476.23 while the NASDAQ rose 0.35% to 14,331.13. The S&P 500 also rose, gaining, 0.30% to 4,568.63.

    Check This Out: How To Earn $500 A Month From NVIDIA Stock After Last Week's Strong Earnings Report

     

    Leading and Lagging Sectors

     

    Real estate shares rose by 1.1% on Wednesday.

    In trading on Wednesday, communication services shares fell by 1%.

     

    Top Headline

     

    The EIA said crude oil inventories in the U.S. increased by 1.609 million barrels in the week ending Nov. 24, compared to a 8.701 million increase in the prior period, and versus market estimates of a 0.933 million decline.

     

    Equities Trading UP

     

    Vivos Therapeutics, Inc. (NASDAQ:VVOS) shares shot up 215% to $13.88. Vivos Therapeutics received FDA 510(k) clearance for treating severe obstructive sleep apnea (OSA) in adults using the Vivos' removable CARE (Complete Airway Repositioning and/or Expansion) oral appliances.

    Shares of Rover Group, Inc. (NASDAQ:ROVR) got a boost, shooting 28% to $10.92 after the company announced it agreed to be acquired by Blackstone in a $2.3 billion transaction.

    Fluence Energy, Inc. (NASDAQ:FLNC) shares were also up, gaining 26% to $25.46 after the company reported fourth-quarter financial results and initiated FY24 revenue guidance.

     

    Equities Trading DOWN

     

    BioVie Inc. (NASDAQ:BIVI) shares dropped 62% to $1.9201 after the company announced topline efficacy data from its Phase 3 trial of NE3107 for mild to moderate Alzheimer's disease.

    Shares of Seelos Therapeutics, Inc. (NASDAQ:SEEL) were down 40% to $1.4350 after the company reported pricing of $5.55 million public offering.

    Farfetch Limited (NYSE:FTCH) was down, falling 46% to $1.1390. Farfetch said it will not announce its third quarter financial results and will not hold its related conference call earlier scheduled for Nov. 29, 2023.

    Also Check This Out: Jim Cramer: Buy Shares Of This Personal Computer Giant, Wait For 'A Little Bit Of Pullback'

     

    Commodities

     

    In commodity news, oil traded up 1.2% to $77.29 while gold traded up 0.1% at $2,061.30.

    Silver traded up 0.6% to $25.44 on Wednesday while copper fell 0.1% to $3.8380.

     

    Euro zone

     

    European shares were mostly higher today. The eurozone’s STOXX 600 gained 0.35%, London’s FTSE 100 fell 0.44% while Spain’s IBEX 35 Index rose 0.78% The German DAX rose 1.03% French CAC 40 rose 0.20%, while Italy’s FTSE MIB Index rose 0.93%.

    The industry confidence indicator in the Eurozone declined to -9.5 in November versus a revised reading of -9.2 in the prior month, while economic sentiment indicator rose to 93.8 in November versus the revised reading of 93.5.

    Consumer credit in the UK increased by £1.289 billion in October versus a revised £1.370 billion in the earlier month. The manufacturing confidence index in Italy rose to 96.6 in November versus 96.1 a month ago, while consumer confidence index in Italy climbed to 103.6 in November from 101.6 in the prior period. Retail sales in Spain surged by 5% year-over-year in October versus a revised 6.3% increase in the previous month, while consumer price inflation rate fell to 3.2% year-over-year in November.

     

    Asia Pacific Markets

     

    Asian markets closed mostly lower on Wednesday, with Japan’s Nikkei 225 falling 0.26%, Hong Kong’s Hang Seng Index falling 2.08% and China’s Shanghai Composite Index falling 0.56%. India’s S&P BSE Sensex, meanwhile, climbed 1.1%.

    The Domestic Supply Price Index in Singapore fell 2.2% year-over-year in October compared to a revised 0.5% decline in the earlier month.

     

    Economics

     

    The US economy grew an annualized 5.2% in the third quarter, compared to 4.9% in the preliminary estimate, and higher than market estimates of 5%.

    Corporate profits in the U.S. jumped by 4.1% from the prior quarter to $2.709 trillion during the third quarter.

    The U.S. trade deficit in goods increased to $89.8 billion in October versus a revised $86.8 billion in the prior month.

    Wholesale inventories in the U.S. declined by 0.2% month-over-month in October, compared to a revised 0.1% increase in the previous month.

    The EIA said crude oil inventories in the U.S. increased by 1.609 million barrels in the week ending Nov. 24, compared to a 8.701 million increase in the prior period, and versus market estimates of a 0.933 million decline.

    Now Read This: Top 5 Consumer Stocks That May Implode In November

    Get the next $BIVI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BIVI
    $FLNC
    $FTCH
    $ROVR

    CompanyDatePrice TargetRatingAnalyst
    Fluence Energy Inc.
    $FLNC
    2/10/2026$24.00Hold → Buy
    Jefferies
    Fluence Energy Inc.
    $FLNC
    12/8/2025$18.00Buy → Hold
    Johnson Rice
    Fluence Energy Inc.
    $FLNC
    12/8/2025$15.00Neutral → Underperform
    Mizuho
    Fluence Energy Inc.
    $FLNC
    11/26/2025$16.00Underperform → Hold
    Jefferies
    Fluence Energy Inc.
    $FLNC
    10/21/2025$9.00Neutral → Underperform
    BNP Paribas Exane
    Fluence Energy Inc.
    $FLNC
    8/13/2025$5.00Hold → Reduce
    HSBC Securities
    Fluence Energy Inc.
    $FLNC
    7/23/2025Buy → Neutral
    Seaport Research Partners
    Fluence Energy Inc.
    $FLNC
    7/14/2025$10.00Outperform → Neutral
    Mizuho
    More analyst ratings

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Fluence upgraded by Jefferies with a new price target

    Jefferies upgraded Fluence from Hold to Buy and set a new price target of $24.00

    2/10/26 7:57:53 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Fluence downgraded by Johnson Rice with a new price target

    Johnson Rice downgraded Fluence from Buy to Hold and set a new price target of $18.00

    12/8/25 10:44:01 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Fluence downgraded by Mizuho with a new price target

    Mizuho downgraded Fluence from Neutral to Underperform and set a new price target of $15.00

    12/8/25 8:22:01 AM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CEO Do Cuong V bought 5,000 shares (SEC Form 4)

    4 - BIOVIE INC. (0001580149) (Issuer)

    8/13/25 4:05:17 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Arnold Cynthia A bought $194,641 worth of shares (33,000 units at $5.90), increasing direct ownership by 62% to 86,202 units (SEC Form 4)

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    5/15/25 7:53:05 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    President and CEO Nebreda Julian bought $49,684 worth of shares (9,450 units at $5.26), increasing direct ownership by 8% to 129,905 units (SEC Form 4)

    4 - Fluence Energy, Inc. (0001868941) (Issuer)

    3/17/25 4:07:13 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Johnson Gregg C claimed ownership of 3,997 shares (SEC Form 3)

    3 - Vivos Therapeutics, Inc. (0001716166) (Issuer)

    2/13/26 8:36:30 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Medical Officer Palumbo Joseph M

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:03:29 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 4 filed by Chief Financial Officer Kim Joanne Wendy

    4 - BIOVIE INC. (0001580149) (Issuer)

    1/9/26 5:03:04 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BioVie Announces Abstracts Accepted for Presentation at the 2026 American College of Psychiatrists Annual Meeting

    CARSON CITY, Nev., Feb. 12, 2026 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of two abstracts from studies on its lead candidate bezisterim (NE3107), in the treatment of Alzheimer's Disease and Long COVID at the 2026 American College of Psychiatrists (ACP) annual meeting, to be held February 18-22, in Bonita Springs, FL. The two abstracts have been accepted for presentation as posters during a session to be held on February 18, 2026. Details of the abstracts are as follows: Abstract Title: Bezisterim-Associated Anti-i

    2/12/26 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vivos Therapeutics and SoundHealth Announce Collaboration to Expand Access to SoundHealth's Groundbreaking FDA-Cleared Allergy and Sleep Technologies

    Vivos adds more cutting-edge products to its roster serving the breathing and sleep wellness market LITTLETON, Colo., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company'') (NASDAQ:VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders, and SoundHealth, a Silicon Valley based health technology company focused on AI enabled, clinically proven allergy and sleep therapeutics, today announced a collaboration to advance public awareness and access to SoundHealth's consumer-focused airway and sleep health technologies. The collaboration leverages Vivos' extensive national network of over 2,00

    2/5/26 8:45:00 AM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    Fluence Energy, Inc. Reports First Quarter 2026 Results; Reaffirms Fiscal Year 2026 Guidance

    ARLINGTON, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ:FLNC) ("Fluence" or the "Company"), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months ended December 31, 2025. Financial Highlights for Fiscal Quarter ended December 31, 2025 Revenue of approximately $475.2 million, which represents an increase of approximately 154.4% from the same quarter last year.GAAP gross profit margin of approximately 4.9%, and adjusted gross profit margin1 of 5.6%. First quarter 2026 GAAP gross profit margin includes additional estimated costs on two projects, a majority o

    2/4/26 4:05:00 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Fluence Energy Inc.

    SCHEDULE 13G/A - Fluence Energy, Inc. (0001868941) (Subject)

    2/9/26 4:30:03 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    SEC Form 10-Q filed by BioVie Inc.

    10-Q - BIOVIE INC. (0001580149) (Filer)

    2/6/26 5:01:18 PM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Vivos Therapeutics Inc. filed SEC Form 8-K: Leadership Update

    8-K - Vivos Therapeutics, Inc. (0001716166) (Filer)

    2/6/26 4:05:34 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Financials

    Live finance-specific insights

    View All

    Fluence Energy, Inc. Reports First Quarter 2026 Results; Reaffirms Fiscal Year 2026 Guidance

    ARLINGTON, Va., Feb. 04, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ:FLNC) ("Fluence" or the "Company"), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months ended December 31, 2025. Financial Highlights for Fiscal Quarter ended December 31, 2025 Revenue of approximately $475.2 million, which represents an increase of approximately 154.4% from the same quarter last year.GAAP gross profit margin of approximately 4.9%, and adjusted gross profit margin1 of 5.6%. First quarter 2026 GAAP gross profit margin includes additional estimated costs on two projects, a majority o

    2/4/26 4:05:00 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Fluence Energy, Inc. Announces First Quarter Earnings Release Date, Conference Call and Webcast

    ARLINGTON, Va., Jan. 15, 2026 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ:FLNC) ("Fluence" or the "Company"), announced today that it will report earnings for the first quarter ended December 31st, 2025, on Wednesday, February 4th, 2026, after market close. The Company will conduct a teleconference starting at 8:30 a.m. EST on Thursday, February 5th, 2026, to discuss the results. To participate, analysts are required to register by clicking Fluence Energy Q1 2026 Earnings Call Registration Link. Once registered, analysts will be issued a unique PIN number and dial-in number. Analysts are encouraged to register at least 15 minutes before the scheduled start time. General audience par

    1/15/26 4:30:00 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    Fluence Energy, Inc. Reports 2025 Financial Results and Initiates 2026 Guidance

    ARLINGTON, Va., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Fluence Energy, Inc. (NASDAQ:FLNC) ("Fluence" or the "Company"), a global market leader delivering intelligent energy storage, operational services, and asset optimization software, today announced its results for the three months and full fiscal year ended September 30, 2025.   Fiscal Year 2025 Financial Highlights Revenue of $2.3 billion for fiscal year 2025 and $1.0 billion for the fourth quarter, compared to $2.7 billion and $1.2 billion from the same periods in fiscal 2024, respectively.GAAP gross profit margin improved to approximately 13.1% for fiscal year 2025 and approximately 13.7% for the fourth quarter, compared to 12.6% and

    11/24/25 4:05:00 PM ET
    $FLNC
    Industrial Machinery/Components
    Miscellaneous

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Leadership Updates

    Live Leadership Updates

    View All

    Vivos Therapeutics Adds to Management Team to Support Expansion and Growth

    LITTLETON, Colo., July 30, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (NASDAQ:VVOS) ("Vivos" or the "Company"), a pioneering medical technology company revolutionizing the treatment of obstructive sleep apnea (OSA) and snoring, today announced the appointments of Michael (Mike) E. Bruhn as its Executive Vice President of Business Operations Integration, and Dr. Terry Jones as its new Senior Vice President of Human Resources. These hires demonstrate Vivos' commitment to the successful implementation and expansion of its new sleep testing center and direct patient treatment operations, highlighted by Vivos' recent acquisition of The Sleep Center of Nevada and Vivos' ongoing, active e

    7/30/25 8:45:00 AM ET
    $VVOS
    Medical/Dental Instruments
    Health Care

    BioVie Unveils Corporate Advisory Board Featuring Neuralink Co-Founder, Former Executives from Mastercard and Apple, and High-Impact Industry Leaders to Advance BioVie Mission and Growth

    The seven-member Board includes Cedars-Sinai brain health leader Dr. Zaldy Tan, Parkwood marketing powerhouse Justina Omokhua, and Neuralink visionary Tim Gardner Each Board member brings deep personal conviction and cross-sector expertise to unlock value and reshape care in Alzheimer's, Parkinson's and other neuroinflammatory disorders CARSON CITY, Nev., May 05, 2025 (GLOBE NEWSWIRE) -- BioVie Inc. (NASDAQ:BIVI) ("BioVie" or the "Company"), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, today announced the formation of its Corporate Advisory Board – a coalition of seven powerhous

    5/5/25 8:00:00 AM ET
    $BIVI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    OPAL Fuels Appoints Kazi Hasan as Chief Financial Officer

    Proven energy industry executive brings over 25 years of extensive financial, operational, and strategic leadership experience in energy sector to drive disciplined growth and value creation OPAL Fuels Inc. (NASDAQ:OPAL), today announced the appointment of Kazi Hasan as Chief Financial Officer, effective February 3, 2025. Mr. Hasan succeeds Scott Contino, who has served as interim CFO since October 2023. Mr. Contino will continue in his role as Chief Financial Officer of the Company's sponsor, Fortistar. With over 25 years of operational, financial, and strategic leadership experience in the power, utility, and renewable energy sectors, Mr. Hasan has a proven track record of creating sh

    2/3/25 4:15:00 PM ET
    $AES
    $FLNC
    $OPAL
    Electric Utilities: Central
    Utilities
    Industrial Machinery/Components
    Miscellaneous

    $BIVI
    $FLNC
    $FTCH
    $ROVR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    12/4/24 1:29:12 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Seelos Therapeutics Inc.

    SC 13G/A - SEELOS THERAPEUTICS, INC. (0001017491) (Subject)

    11/14/24 7:32:44 PM ET
    $SEEL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Vivos Therapeutics Inc.

    SC 13G/A - Vivos Therapeutics, Inc. (0001716166) (Subject)

    11/14/24 4:49:30 PM ET
    $VVOS
    Medical/Dental Instruments
    Health Care